Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.36 - $3.65 $57,120 - $153,300
-42,000 Reduced 16.26%
216,300 $296,000
Q1 2024

May 15, 2024

BUY
$3.52 - $9.59 $796,224 - $2.17 Million
226,200 Added 704.67%
258,300 $968,000
Q4 2023

Feb 14, 2024

SELL
$5.97 - $10.36 $23,283 - $40,404
-3,900 Reduced 10.83%
32,100 $314,000
Q3 2023

Nov 14, 2023

SELL
$8.23 - $13.93 $169,538 - $286,958
-20,600 Reduced 36.4%
36,000 $300,000
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $346,956 - $488,940
34,800 Added 159.63%
56,600 $752,000
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $173,092 - $262,036
21,800 New
21,800 $252,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $393M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.